Edition:
United Kingdom

Cidara Therapeutics Inc (CDTX.OQ)

CDTX.OQ on NASDAQ Stock Exchange Global Market

1.54USD
14 Jun 2019
Change (% chg)

$-0.03 (-1.91%)
Prev Close
$1.57
Open
$1.56
Day's High
$1.59
Day's Low
$1.54
Volume
15,041
Avg. Vol
32,299
52-wk High
$5.75
52-wk Low
$1.41

About

Cidara Therapeutics Inc., is a clinical-stage biotechnology company focused on developing new anti-infectives. The Company’s lead product candidate is rezafungin acetate, which is a molecule in the echinocandin class of antifungals for the treatment and prevention of serious invasive fungal infections, including candidemia and... (more)

Overall

Beta: 2.17
Market Cap(Mil.): $41.03
Shares Outstanding(Mil.): 26.64
Dividend: --
Yield (%): --

Financials

  CDTX.OQ Industry Sector
P/E (TTM): -- 103.12 37.45
EPS (TTM): -2.66 -- --
ROI: -112.97 7.69 12.16
ROE: -145.93 8.19 16.93

Earnings vs. Estimates